← Open Payments lookup

DANIEL STORCH: Open Payments

NPI 1790740413 · COLUMBIA, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,059 in 47 payments from 9 companies in 2025. Trend: 2023 $1,260 · 2024 $1,207 · 2025 $1,059

Food & beverage: $1,059
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.13$310
ABBVIE INC.11$192
E.R. Squibb & Sons, L.L.C.8$166
Teva Pharmaceuticals USA, Inc.6$140
Janssen Pharmaceuticals, Inc3$86
Vanda Pharmaceuticals Inc.2$66
Alkermes, Inc.2$47
Axsome Therapeutics, Inc.1$31
Lundbeck LLC1$21

Products named: INGREZZA, VRAYLAR, COBENFY, AUSTEDO XR, INVEGA SUSTENNA, HETLIOZ, ARISTADA, Auvelity.

Industry payments across MD — which companies pay providers there.